Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
Aevi Genomic Medicine, Inc. (CERC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/11/2020 |
4
| COLA MICHAEL F (CEO) has filed a Form 4 on Aevi Genomic Medicine, LLC|
Txns:
| Bought 100,000 shares
@ $2.5, valued at
$250k
|
|
| 02/07/2020 |
4
| ASTRAZENECA PLC (10% Owner) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Bought 12,946,900 shares
@ $0 |
|
| 02/05/2020 |
4
| BARER SOL J (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Disposed/sold 200,000 options to buy
@ $5.22, valued at
$1M
Disposed/sold 200,000 options to buy
@ $5.22, valued at
$1M
Disposed/sold 15,000 options to buy
@ $7.25, valued at
$108.8k
Disposed/sold 15,000 options to buy
@ $6.5, valued at
$97.5k
Disposed/sold 80,000 options to buy
@ $7.01, valued at
$560.8k
Disposed/sold 80,000 options to buy
@ $4.83, valued at
$386.4k
Disposed/sold 80,000 options to buy
@ $1.32, valued at
$105.6k
Disposed/sold 100,000 options to buy
@ $1.55, valued at
$155k
Disposed/sold 74,912 warrants
@ $2.84, valued at
$212.8k
|
|
| 02/05/2020 |
4
| McInaw Michael (Interim CFO) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Disposed/sold 16,107 shares
@ $0
Disposed/sold 6,500 options to buy
@ $5.77, valued at
$37.5k
Disposed/sold 1,500 options to buy
@ $4.91, valued at
$7.4k
Disposed/sold 5,000 options to buy
@ $1.24, valued at
$6.2k
Disposed/sold 5,000 options to buy
@ $1.32, valued at
$6.6k
Disposed/sold 26,250 options to buy
@ $1.55, valued at
$40.7k
Disposed/sold 6,500 options to buy
@ $1.52, valued at
$9.9k
|
|
| 02/05/2020 |
4
| Duncan Barbara Gayle (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Disposed/sold 59,524 shares
@ $0
Disposed/sold 50,000 options to buy
@ $1.55, valued at
$77.5k
Disposed/sold 20,000 options to buy
@ $1.32, valued at
$26.4k
Disposed/sold 20,000 options to buy
@ $4.83, valued at
$96.6k
Disposed/sold 40,000 options to buy
@ $8.09, valued at
$323.6k
Disposed/sold 10,591 options to buy
@ $2.84, valued at
$30.1k
|
|
| 02/05/2020 |
4
| Bayley Matthew D (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Disposed/sold 40,000 options to buy
@ $1.25, valued at
$50k
Disposed/sold 50,000 options to buy
@ $1.55, valued at
$77.5k
|
|
| 02/05/2020 |
4
| GRANO JOSEPH J JR (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Disposed/sold 75,683 shares
@ $0
Disposed/sold 27,000 shares
@ $0
Disposed/sold 56,780 shares
@ $0
Disposed/sold 15,384 shares
@ $0
Disposed/sold 15,000 options to buy
@ $6.5, valued at
$97.5k
Disposed/sold 20,000 options to buy
@ $7.01, valued at
$140.2k
Disposed/sold 20,000 options to buy
@ $1.32, valued at
$26.4k
Disposed/sold 50,000 options to buy
@ $1.55, valued at
$77.5k
Disposed/sold 20,000 options to buy
@ $4.83, valued at
$96.6k
Disposed/sold 7,061 warrants
@ $2.84, valued at
$20.1k
|
|
| 02/05/2020 |
4
| BAUER EUGENE A (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Disposed/sold 165,715 shares
@ $0
Disposed/sold 28,571 options to buy
@ $8.19, valued at
$234k
Disposed/sold 50,000 options to buy
@ $6.7, valued at
$335k
Disposed/sold 20,000 options to buy
@ $7.01, valued at
$140.2k
Disposed/sold 20,000 options to buy
@ $4.83, valued at
$96.6k
Disposed/sold 20,000 options to buy
@ $1.32, valued at
$26.4k
Disposed/sold 50,000 options to buy
@ $1.55, valued at
$77.5k
Disposed/sold 3,530 warrants
@ $2.84, valued at
$10k
|
|
| 02/05/2020 |
4
| CLEMOW ALASTAIR J (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Disposed/sold 57,536 shares
@ $0
Disposed/sold 12,857 options to buy
@ $8.19, valued at
$105.3k
Disposed/sold 12,857 options to buy
@ $6.55, valued at
$84.2k
Disposed/sold 15,000 options to buy
@ $7.25, valued at
$108.8k
Disposed/sold 15,000 options to buy
@ $2.66, valued at
$39.9k
Disposed/sold 50,000 options to buy
@ $6.7, valued at
$335k
Disposed/sold 15,000 options to buy
@ $6.5, valued at
$97.5k
Disposed/sold 20,000 options to buy
@ $7.01, valued at
$140.2k
Disposed/sold 20,000 options to buy
@ $4.83, valued at
$96.6k
Disposed/sold 20,000 options to buy
@ $1.32, valued at
$26.4k
Disposed/sold 50,000 options to buy
@ $1.55, valued at
$77.5k
|
|
| 02/05/2020 |
4
| Children's Hospital of Philadelphia Foundation (10% Owner) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Acquired 38,856,891 shares
@ $0
Disposed of 57,280,927 shares
@ $0
Disposed/sold 2,824,217 options to buy
@ $2.84, valued at
$8M
|
|
| 02/05/2020 |
4
| COLA MICHAEL F (President and CEO) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Disposed/sold 2,267,859 shares
@ $0
Disposed/sold 17,327 options to buy
@ $6.45, valued at
$111.8k
Disposed/sold 292,087 options to buy
@ $7.01, valued at
$2M
Disposed/sold 250,000 options to buy
@ $4.83, valued at
$1.2M
Disposed/sold 250,000 options to buy
@ $4.91, valued at
$1.2M
Disposed/sold 450,000 options to buy
@ $1.51, valued at
$679.5k
Disposed/sold 661,000 options to buy
@ $1.55, valued at
$1M
Disposed/sold 50,000 options to buy
@ $1.32, valued at
$66k
Disposed/sold 1,500,000 options to buy
@ $4.22, valued at
$6.3M
Disposed/sold 21,181 warrants
@ $2.84, valued at
$60.2k
|
|
| 02/05/2020 |
4
| NEIL GARRY ARTHUR (Chief Scientific Officer) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Disposed/sold 2,164,150 shares
@ $0
Disposed/sold 900,000 options to buy
@ $4.22, valued at
$3.8M
Disposed/sold 13,532 options to buy
@ $6.45, valued at
$87.3k
Disposed/sold 200,000 options to buy
@ $7.01, valued at
$1.4M
Disposed/sold 200,000 options to buy
@ $4.83, valued at
$966k
Disposed/sold 200,000 options to buy
@ $4.91, valued at
$982k
Disposed/sold 100,000 options to buy
@ $1.32, valued at
$132k
Disposed/sold 13,334 options to buy
@ $2.84, valued at
$37.9k
Disposed/sold 300,000 options to buy
@ $1.51, valued at
$453k
Disposed/sold 261,000 options to buy
@ $1.55, valued at
$404.6k
|
|
| 12/09/2019 |
4
| COLA MICHAEL F (President and CEO) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Bought 2,049,376 shares
@ $0.134, valued at
$274.6k
|
|
| 12/09/2019 |
4
| NEIL GARRY ARTHUR (Chief Scientific Officer) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Bought 2,049,376 shares
@ $0.134, valued at
$274.6k
|
|
| 12/09/2019 |
4
| BARER SOL J (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Gifted 153,846 shares
@ $0
Gifted 153,846 shares
@ $0
Gifted 365,854 shares
@ $0
Gifted 365,854 shares
@ $0
Disposed of 2,551,020 shares
@ $0
Acquired 2,551,020 shares
@ $0
Sold 4,098,752 shares
@ $0.134, valued at
$549.2k
|
|
| 11/13/2018 |
4
| GRANO JOSEPH J JR (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Bought 26,000 shares
@ $1.162, valued at
$30.2k
Bought 21,000 shares
@ $1.17, valued at
$24.6k
Bought 21,000 shares
@ $1.15, valued at
$24.2k
|
|
| 08/17/2018 |
4
| BARER SOL J (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Bought 2,551,020 shares
@ $0.96, valued at
$2.4M
|
|
| 08/17/2018 |
4
| Children's Hospital of Philadelphia Foundation (10% Owner) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Bought 2,551,020 shares
@ $0.96, valued at
$2.4M
|
|
| 06/19/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2018 |
4
| COLA MICHAEL F (President and CEO) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Granted 661,000 options to buy
@ $1.55, valued at
$1M
|
|
| 06/18/2018 |
4
| NEIL GARRY ARTHUR (Chief Scientific Officer) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Granted 261,000 options to buy
@ $1.55, valued at
$404.6k
|
|
| 06/18/2018 |
4
| Piper Brian (CFO & Corporate Secretary) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Granted 238,000 options to buy
@ $1.55, valued at
$368.9k
|
|
| 06/18/2018 |
4
| GRANO JOSEPH J JR (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.55, valued at
$77.5k
|
|
| 06/18/2018 |
4
| BARER SOL J (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.55, valued at
$155k
|
|
| 06/18/2018 |
4
| BAUER EUGENE A (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.55, valued at
$77.5k
|
|
| 06/18/2018 |
4
| CLEMOW ALASTAIR J (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.55, valued at
$77.5k
|
|
| 06/18/2018 |
4
| Duncan Barbara Gayle (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.55, valued at
$77.5k
|
|
| 05/16/2018 |
4
| Piper Brian (CFO & Corporate Secretary) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Granted 270,000 options to buy
@ $1.51, valued at
$407.7k
|
|
| 05/16/2018 |
4
| COLA MICHAEL F (President and CEO) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Granted 450,000 options to buy
@ $1.51, valued at
$679.5k
|
|
| 05/16/2018 |
4
| NEIL GARRY ARTHUR (Chief Scientific Officer) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Granted 300,000 options to buy
@ $1.51, valued at
$453k
|
|
| 12/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/18/2017 |
4
| COLA MICHAEL F (President and CEO) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Bought 119,047 shares
@ $1.26, valued at
$150k
Bought 21,181 warrants
@ $2.84, valued at
$60.2k
|
|
| 10/18/2017 |
4
| BAUER EUGENE A (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Bought 19,841 shares
@ $1.26, valued at
$25k
Bought 3,530 warrants
@ $2.84, valued at
$10k
|
|
| 10/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|